chr9-114478626-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015404.4(WHRN):c.764G>A(p.Gly255Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000795 in 1,614,008 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_015404.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WHRN | NM_015404.4 | c.764G>A | p.Gly255Asp | missense_variant | 2/12 | ENST00000362057.4 | NP_056219.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WHRN | ENST00000362057.4 | c.764G>A | p.Gly255Asp | missense_variant | 2/12 | 1 | NM_015404.4 | ENSP00000354623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00434 AC: 661AN: 152230Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.00103 AC: 258AN: 250302Hom.: 1 AF XY: 0.000716 AC XY: 97AN XY: 135438
GnomAD4 exome AF: 0.000426 AC: 622AN: 1461660Hom.: 11 Cov.: 31 AF XY: 0.000349 AC XY: 254AN XY: 727138
GnomAD4 genome AF: 0.00434 AC: 661AN: 152348Hom.: 6 Cov.: 32 AF XY: 0.00416 AC XY: 310AN XY: 74500
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 17, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 31, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 25, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 08, 2012 | Gly255Asp in exon 2 of DFNB31: This variant is not expected to have clinical sig nificance because it is not located within the splice consensus sequence, and ha s been identified in 1.3% (49/3689) of African American chromosomes from a broad , though clinically unspecified population (NHLBI Exome Sequencing Project; http ://evs.gs.washington.edu/EVS, dbSNP rs79509430). - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at